Navigation Links
Solos Endoscopy, Inc. Announces Recapitalization Plan for 2011
Date:11/19/2010

BOSTON, Nov. 19, 2010 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company's management has approved its 2011 recapitalization plan in order to position itself for growth over the next twelve months. The recapitalization plan is designed to increase financial flexibility for Solos and its shareholders.

The recapitalization plan allows Solos greater flexibility to utilize the assets of the Company in the future for corporate purposes; including raising capital, acquisitions or employee compensation, with limited dilution of existing stockholder voting rights.

"We are very pleased that the recapitalization allows us to pursue our existing strategy more aggressively," stated Bob Segersten, President of Solos Endoscopy, Inc.

Throughout the remainder of 2010, the Company will continue its new product development for the MammoView® product line. In addition, Solos plans to achieve market expansion through its efforts to meet the requirements of the ISO 13485 standard and ultimately obtain the CE Mark and the permission to sell medical devices in the European Union and Canada.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a HealthCare instrument company whose mission is to develop and market high quality and innovative instruments for the screening, diagnosis, treatment and management of medical conditions. Additional information on its FDA approved products is available on the Company's website at: www.solosendoscopy.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.


'/>"/>
SOURCE Solos Endoscopy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Solos Endoscopy, Inc. Revenue Grows 34.8% for Third Quarter 2010
2. Solos Endoscopy, Inc. Announces Results of 2010 Annual Shareholder Meeting
3. Solos Endoscopy, Inc. to Hold Annual Shareholder Meeting September 28, 2010
4. Solos Endoscopy, Inc. Develops Relay Lense Adapter System For MammoView® Product Line
5. Solos Endoscopy, Inc. Increases Revenues by 10 Percent for First Quarter 2010 as Compared to First Quarter 2009
6. Solos Endoscopy, Inc. Appoints Experienced CFO To Financial Leadership Amidst Growth
7. Solos Endoscopy, Inc. Granted U.S. Trademark for MammoView(R)
8. Solos Endoscopy, Inc. Set To Develop European Union Conforming CE Mark Technical File
9. Solos Endoscopy, Inc. Set To Develop New Polymer Dilator For MammoView(TM) System
10. Solos Endoscopy, Inc. Retains Expert Resource to Meet Requirements for ISO 13485 Quality Management System Initiative
11. Solos Endoscopy, Inc.s Breast Endoscopy System Featured in February Issue of General Surgery News
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... Idaho , Jan. 12, 2017  Albertsons ... by Accreditation Commission for Health Care (ACHC) for ... largest national food and drug chain with this ... for pharmacy patients. Accreditation by ACHC ... national standards to facilitate a higher level of ...
(Date:1/13/2017)... Jan. 13, 2017  Biologics Prescribers Collaborative ... Administration (FDA) for issuing final guidance calling ... This policy is an important win for ... essential for pharmacovigilance, patient safety and transparency. ... voiced to FDA, we remain concerned with "random" suffixes ...
(Date:1/12/2017)... COTTAGE, New York , January 12, 2017 ... to observe steady growth in 2016, reaching beyond US$ 3.8 Bn ... diagnosis, and treatment is anticipated to fuel the demand for PIVC. ... market growth. North America is likely to ... expected to emerge at the fastest rate. ...
Breaking Medicine Technology:
(Date:1/14/2017)... MN (PRWEB) , ... January 14, 2017 , ... ... present the distinctions among their expanding line of activated charcoal products. With more ... the importance of categorizing their products according to how they cater to specific ...
(Date:1/14/2017)... ... ... 3 is a self animating masking transition which allows users to reveal any object or ... - CEO of Pixel Film Studios. , TransFreeze Volume 3 provides FCPX ... next. , To use “Cut-Out First” presets, choose a video clip and hold ...
(Date:1/13/2017)... ... January 13, 2017 , ... A January 10 article ... for 2017 according to the publication, with an emphasis on some new techniques that ... F.I.C.S., F.A.C.S., who is known more casually to his patients and colleagues as Dr. ...
(Date:1/13/2017)... ... ... inventor from Pahrump, Nev., used an unsavory medical experience to think of a way to ... urine bag for a half year due to lazy bladder," he said. "Keeping these things ... better way to do this." , He then designed and created a prototype of the ...
(Date:1/13/2017)... PA (PRWEB) , ... January 13, 2017 , ... "We ... and attractive to wear," said one of two inventors from Virginia Beach, Va. , ... to normally mundane braces. , The accessories allow braces to be customized to ...
Breaking Medicine News(10 mins):